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The first laboratory of Systems Biology in Ukraine (IMBIG NASU) represents a track record of its scientific
results. They include the pioneered development of a web-based tool for genome-wide surveys of eukaryotic
promoters for the presence of transcription factors binding sites (COTRASIF); the deciphered mechanisms of
the fine-tuned and balanced response of primary hepatocytes to interferon alpha levels recorded after partial
hepatectomy; the elaboration of a novel method of gene regulatory network inference compatible with GRID
environment and the development of a stoichiometric model of folate-related one carbon unit metabolism in
human placenta and its application for the characteristics of the system’s behavior as a whole at different human 
pathologies.
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The beginning of XXI century was marked by the emer-
gence of the new branch in biological sciences – Syst-
ems Biology that is defined as the quantitative analysis
of the dynamic interactions between the components of 
a biological system and aims at understanding the be-
haviour of the system as a whole, as opposed to the be-
haviour of its individual constituents [1]. Systems Bio-
logy recognizes that: the overall systemic features dif-
fer from the collective features of its constituents; each
system has subsystems being itself a subsystem of the
system of higher order; the system has a hierarchic struc- 
ture; it is a dynamic formation, which changes during
its functioning and evolution. Systems Biology uses the
high-throughput technologies of molecular biology,
mathematics, physics, informatics and engineering. It
handles the massive amounts of data; its measurements
must be as quantitative as possible – for the ultimate in-
tegration and modeling this information is a quantita-
tive process; it combines discovery-driven and hypothe-
sis-driven approaches to systems studies; the modeling
is the ultimate objective of systems biology that helps
to understand the mechanistic underpinnings of particu-
lar biological systems phenomena that emerge from the 
integrated operation of the information components
(emergent properties) [2]. Systems Biology promotes
the close cooperation of scientists from different areas
of science and technology. The promises of Systems Bio-
logy are great – from creation of virtual organs to vir-
tual man. It will affect many areas of the biomedical
sciences from drug design to medical treatment going
from the statistically average for typical patient to the
individual with his/her specific geno- and phenotype. 
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 «… we need to overcome the idea, so prevalent in both academic and
bureaucratic circles, that the only work worth taking seriously is highly
detailed research in a speciality. We need to celebrate the equally vital
contribution of those who dare to take what I call «a crude look at the
whole».»
                                        Murray Gell-Mann, Nobel Laureate in Physics, 1994.
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In 2009 the first laboratory of Systems Biology in
Ukraine (Prof. Maria Obolenskaya) was organized   in
the Institute of Molecular Biology and Genetics of
National Academy of Sciences of Ukraine. Herein we
present the initial results obtained by our small group. 
COTRASIF: conservation-aided transcription
factor binding site finder. The transcriptional regula-
tion of gene expression relies on the effects of the trans- 
cription factors (TFs) bound to specific regulatory ele-
ments, transcription factor binding sites (TFBS) in the
promoters of the genes, activating or repressing the
corresponding gene. While experimental identification
of TFBS within single gene promoters is common, with 
no prior information this process is both effort- and ti-
me consuming. Computational prediction of TFBS marks
the potential targets for further experimental verifi-
cation, and presents self-sufficient data on the gene re-
gulation patterns, associated with each specific TF. 
We have developed an easy to use web-based tool
for genome-wide surveys of eukaryotic promoters for
the presence of TFBS [3]. The most common way of re- 
presenting conserved sequences (such as TFBS) is to
use consensus strings (built using IUPAC – Interna-
tional Union of Pure and Applied Chemistry – nomen-
clature) but these strings contain only a small portion of 
the information, available from the set of initial sequen-
ces. Instead, position frequency matrix (PFM) consists
of each of four possible nucleotide counts per each po-
sition of the identified binding site. Position weight
matrix (PWM) represents the complete nucleotide oc-
currence probabilities for each position using position
weight matrices and information content evaluation of
each matrix position [4–7]. It also allows the quantifica-
tion of the similarity between the weight matrix and a
potential TFBS detected in the target sequence [6, 8–
10]. However, even the matrix representation is prone
to information loss: it is perfect for recording single
nucleotide frequencies, but higher order groupings (li-
ke pairs or triplets of nucleotides) are not accounted
for. Joining hidden Markov models (HMMs) to PFM
and PWM helps to preserve this kind of information as
well and yields the method of storing full TFBS cha-
racteristics.
Taking into account the length of matrices used for
TFBS prediction (usually less than 15 nucleotides), the
search may yield numerous false-positive results, occur- 
ring by chance. To reduce their number, and avoid the
loss of sensitivity additional processing of results – ge-
ne orthology information [11, 12], was applied. 
Therefore, a new web-based tool, called CO-
TRASIF, allows conducting genome wide searches of
the user-specified TFBS or sequence sets, and provi-
des an option to filter the list of results based on evolu-
tioary conservation [13]. COTRASIF allows using either
PFM, or a set of sequences. When a set of sequences is
provided, the hybrid HMM-PWM search method is
used instead of the PWM-only search method. CO-
TRASIF contains its own, regularly updated database of
eukaryotic promoters (automatically imported from En-
sembl genome annotations), integrated JASPAR CORE
database of high-quality TFBS matrices and evolutio-
nary conservation filter. Therefore COTRASIF is a ful- 
ly integrated solution which is freely available at http:// 
biomed.org.ua/COTRASIF/. There is an extensive
online help available for the tool. 
COTRASIF application. COTRASIF has become 
a popular tool all over the world that is clearly demon-
strated by the Table 1. 
Using COTRASIF we identified and analyzed the
rat genes of the potential primary response to interferon 
alpha (IFNα). The dominating IFNa transduction path-
way is realized via ISGF3 transcription factor (interfe-
Countries Total number of tasks Percent of tasks
United States 1132 23.80
Ukraine 879 18.48
Germany 361 7.59
United Kingdom 289 6.08
China 217 4.56
France 146 3.07
Canada 144 3.03
Norway 128 2.69
Italy 126 2.65
India 102 2.14
Other 1233 25.9
Total 4,757 100 %
Table 1
Statistics of COTRASIF visits by countries
ron-stimulated gene factor 3), which binds specifically
to ISRE (interferon-stimulated response element) [14].
Thus, searching for ISRE has revealed 162 genes with
putative conserved ISRE among 17725 protein-coding
genes of Rattus norvegicus. Using web-based tool Fa-
tiGO [15] we have predicted previously unknown po-
tential targets of IFNa referring to the complement sys-
tem and components of synapse. The experimental veri-
fication of this prediction is currently in progress. 
Gene expression profiling. Gene expression profi- 
ling is the measurement of expression of thousands of
genes at once, to create a global picture of transcripto-
me and ultimate system level information for inference
of gene regulatory network. There are two principal ap- 
proaches used for the gene expression profiling – based 
on hybridization of RNA sample with previously iden-
tified target genes attached to a solid surface (micro-
array) and sequence based technique (e. g. RNA-seq). 
We have analyzed the gene expression profile in
primary rat hepatocytes isolated from intact liver and
treated during 3 h and 6 h with IFNα (250 U/ml) [16].
The early up-regulated expression, specific antiviral ac-
tivity and activated intracellular IFNα signaling were
recently discovered in regenerating rat liver [17–20]
against a background of different other manifestations
of the innate immune response [21–23]. To approach
the problem we mimicked in vitro the quantitative and
temporal local levels of IFNα after partial hepatectomy 
(PH) and delineate the response of primary hepatocytes 
to such treatment.
The gene expression profile was analyzed with
GeneChip® Rat Genome 230 2.0 Array (Affymetrix). It
provides comprehensive coverage of the transcribed
rat genome on a single array, comprised of more than
31000 probe sets, analyzing over 30000 transcripts and
variants from over 28000 well-substantiated rat genes. 
The analysis of gene expression profiles after 3 h-
and 6 h-incubation of hepatocytes with IFNα revealed
24 and 128 differentially expressed up-regulated genes,
a smaller number than that induced by longer treatment
with higher doses of IFNα, but only partly overlapping
with them. In total, they differ in that the response is
smaller in magnitude, that there is a simultaneous ex-
pression of activators and inhibitors of transcription and
intracellular signaling, co-regulators of transcription
factors are involved, as well as several specific modifi-
ers of proteins. As such the response is cell and situation
specific [24, 25] and temporally regulated. 
The sequence of how the differentially expressed
genes enter the process is of principal biological impor- 
tance. At the early stage the cells exploit the strategic
advantage of the energy saving principle by using avai- 
lable resources and protein changes to get the fastest res- 
ponse: autophagy to eliminate unneeded cellular mate-
rials; reversible ISGylation of preexisting proteins ex-
ceeding other types of protein modification; partial inhi-
bition of the energy consuming translation; co-activa-
tion of preexisting nuclear receptors to provide faster
changes in gene expression in comparison with other
transcription factors acting as target proteins of slower
responding signaling cascades; switching the mitochon- 
drial dNTP synthesis to the salvage pathway and, last-
ly, the «insistent appeal» to other hepatic cells for their
involvement in the process.
The further development of the response is asso-
ciated with a more intensive nuclear control of gene ex- 
pression via up-regulated STAT1, STAT2 and IRF9
against the background of activated preexisting Jak/
STAT, PI3K/Akt and p38/MAPK pathways; enlarge-
ment of the list of differentially expressed genes and in- 
creasing the response of previously expressed genes (in 
most cases) and involving restraining factors. The si-
multaneous expression of proinflammatory and restrai- 
ning factors seems to be a distinguishing feature of the
hepatocyte response to a specified IFNα impact. The
propagation of IFNα signaling via activated transmis-
sion from MAVS (mitochondrial antiviral signalling
protein) to TBK1 (TANK-binding kinase 1) may be op- 
posed by inhibition of RIG1 (Retinoic Acid Inducible
Gene 1 Protein) and its pathway; T cell activation by CXC 
ligands and MHC complexes by T cell inhibition via ne-
gative co-receptor PD-1; initiator caspase 8 by the most
potent cellular inhibitor of apoptosis, XIAP [16]. 
Thus, the realization of protein activities encoded
by differentially expressed genes would affect all regu-
latory levels of gene expression and provide a time-de-
pendent, strictly balanced and energy sparing response. 
We hypothesize that elevated expression of IFNα at the 
beginning of regeneration process may induce the
similar processes.
There are several facts either confirming the invol-
vement of several genes that in vitro respond to IFNα or
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arguing in favor of their potential participation in liver
restoration (Table 2). The formal resemblance bet- ween 
the expression of a limited number of genes in our
experiment and the processes activated during the tran-
sition period after PH is not sufficient to consider IFNα
as a candidate regulator at this stage of liver restoration, 
but it offers a challenge for a more in-depth study and
gives a potential clue to elucidating its place in the con-
text of liver restoration. 
Inferring gene-regulatory network. Essentially all
biological functions of a living cell are carried out
through the interplay between many protein-coding and
protein-noncoding genes. Identifying these gene net-
works and their functions is a main challenge in sys-
tems biology, which using the high-throughput biotech-
nologies enables the collection of large-scale genomics 
data on gene expressions, genome-wide location of
transcription factor binding sites, protein–protein inter- 
actions, genetic variations, and many other types of data.
These data provide valuable system level information
on different aspects of the complex biological processes
and make it possible to infer the underlying networks. 
Various models have been proposed in literature to
represent and simulate the behavior of Gene Regulato-
ry Networks (GRNs). Boolean, Bayesian Networks, Dif-
ferential Equations, Information Theory, supervised
learning methods are some of the prominent ones. Boo- 
lean networks use a binary variable (gene is «on» or
«off») to represent the state of a gene activity and a di-
rected graph to represent genes connections. The state
of a particular gene in time t + 1 can be described as
Boolean function of other genes in time t. Bayesian mo-
dels make use of Bayes rules and consider gene expres-
sions as random variables. In Bayesian models each no- 
de is associated with a probability function that takes as 
input a particular set of values for the node’s parent va-
riables and gives the probability of the variable repre-
sented by the node. Difference and differential equa-
tions allow more detailed descriptions of network dy-
namics, by explicitly modeling the concentration chan-
ges of molecules over time. Information theory models
correlate two genes by means of a mutual information
correlation coefficient and a threshold. 
Each of the models has their strength and weakness
and for each of them it is possible to apply different me- 
thods which may be realized by different algorithms.
Despite substantial research on this topic, it remains a
great challenge to elucidate the complete network due
to the complexity of the transcription processes and the
noisy nature of high-throughput raw data [26–28].
One of the significant problems the scientist encoun-
ters is a NP-hard (Non-deterministic Polynomial-time
hard)  character of the GRN inference that is the time re-
quired to create GRN using any currently known algo-
rithm increases very quickly as a size of the data grows
[29]. To overcome the problem the modern reconstruc-
tion algorithms use heuristics that reduce the field of
search at expense of the accuracy of reconstruction and
its biological relevance. 
We proposed a novel integrated approach to infer
GRN – an ensembl-method that combines the networks 
obtained by other methods, selects their best traits, and
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Characteristics  
Compromised liver restoration with KO genes Up-regulated individual mRNAs* Up-regulated protein content and enzyme activityt
Erα, Pparα, Rar/Rxr Ifnαh, t, StatIh, Stat2h, Atf2h, Atf4h Accumulation of autophagosomes
Stat5, Nf-κB Mx1h, Mx2h Lysosome proteolysis
Dab, Casp8, SCF(β-TrCP) complex p GANK t28 Caspase 8
Uba7t, Trim25t
B2m Eif2αk2h Cytosolic 5'-nucleotidase
Casp8t 3' → 5'-exonuclease
*«h» and «t» designate hepatocytes and liver tissue which RNA and protein were used for the study.    
Table 2
Characteristics of regenerating liver related to the in vitro hepatocytes response to IFNα [16]
uses Grid environment that enables the inference in rea-
sonable time with minimal euristics (if needed) due to
high level of parallelization of calculations [30]. The
six sequential steps testifying the applicability of spe-
cific combination of the models with methods and algo-
rithms for the tasks parallelization in GRID environ-
ment are represented in the Fig. 1. The GRN reconstruc-
tion technique was validated and evaluated by the «gol- 
den standard» (The Dialogue for Reverse Engineering
Assessments and Methods (DREAM) program; http://
www.the-dream-project.org/) and synthetic networks.
The DREAM provides the expression data and corres-
ponding GRNs and encourages researchers to develop
new efficient computation methods and evaluate them
by comparison with the results of the «golden standard».
The synthetic GRNs of different size were self-made
on the basis of DREAM-4 InSilico Challenge (http://
gnw.sourceforge.net/dreamchallenge.html#dream4chal
lenge) by the GeneNetWeaver (http://gnw.sourcefor ge. 
net) tool [30]. 
The conventional AUROC (the Area under the Re-
ceiver operating Characterisics curve) and the AUPR (the
Area Under Precision/Recall curve) evaluation measu-
res have been used to compare the obtained networks
with the above mentioned standards*. The best methods
(Aracne, Banjo, CLR, MrNet) were chosen by these crite- 
ria and compared with the ensembl-methhod that has
combined these methods using their best features. The
characteristics of ensembl-method appeared substantial-
ly better than those of each specified methods but its ob-
vious advantage is that it may be used in GRID environ-
ment. The pilot inference of GRN in rat hepatocytes,
treated with different pharmacological and xenobiotic
compounds (7700 genes, 5288 animal studies; gene ex- 
pression Omnibus, GEO; http://www. ncbi.nlm.nih.
gov/geo/query/acc.cgi?acc=GSE8858), has taken 15
days of parallel computations on GRID while serial com-
putations on average modern computer would take up to
580 days (unpublished). So, the ensembl-method combi-
ned with GRID technologies has definite advantage and 
is admissible for inferring GRNs. Our virtual organiza-
tion Sysbio is registerd in Ukrainian National grid.
A booming of computational biology, which sheer- 
ly was a theoretician’s fantasy twenty years ago, has be-
come a reality. Various GRNs are successfully recon-
structed from different species, tissues and cells [31–
33]. But the challenging problems in this area still re-
main. Just to name a few, the number of variables (ge-
nes) in a system under investigation is considerably mo-
re than the number of measurements (observations) of
those variables that does not correspond to the require-
ments of matrix formation; the absence of reference GRN
for human and other model mammalian organisms. The-
re are several propositions to overcome these problems
[34, 35] but the elaboration of new methods and optimi-
zation of the existing ones are greatly encouraged. 
Modeling and simulation of folate-mediated one-
carbon metabolism in human placenta. Folateme-
diated one-carbon metabolism (FOCM) in human pla-
centa is one of the areas of our scientific interests [37 –
39]. The FOCM is represented by a network of intercon-
nected metabolic pathways necessary for the synthesis
of purine nucleotides, thymidylate, the remethylation
of homocysteine (Hcy) to methionine (Met), prevalent
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Fig. 1. The scheme of step-by-step evaluation of ensembl-method
*AUROC is evaluated using the ratio between the true positive (TP) rate 
and the false positive (FP) rate as a performance measure. The AUPR is
calculated using the ratio between precision (i. e. TP/(TP + FP)) and re- 
call (i. e. TP/(TP + FN) with FN denominating the number of false nega-
tive data. 
majority of methylation reactions and the synthesis of
glutathione (Fig. 2).  
Thus, FOCM is involved in the fundamental mole-
cular functions and biological processes connected with
them – proliferation, transcription, translation, mainte-
nance of cellular redox state and detoxication [40, 41].
According to the specificity of its biochemical reactions
the FOCM network is highly sensitive to nutritional
status of amino acids and several vitamins (folate and
vitamins B12, B6, and B2), that are cofactors in nume-
rous FOCM reactions, and to numerous penetrant gene
variants as the majority of its enzymes are highly poly-
morphic [42]. At the same time it has to be robust and
steady as it is involved in fundamental biological pro-
cesses. The regulation of this balance is an intriguing
question. Numerous pathological states with unknown
etiologies (cancer, cardiovascular diseases etc.) are as-
sociated with perturbations in this network, particular-
ly during pregnancy, affecting the development of a fe-
tus, the health of the child post partum and maternal
health [43, 44].
Although a considerable research has elucidated
biochemical details of FOCM, most studies have focu-
sed primarily on single reactions or pathways in isola-
tion, failing to capture the overall functioning of the
system. Even large-scale international trials would not
be able to experimentally follow the FOCM variability
in its endless combinations. Mathematical modeling has
proven to be a powerful tool for filling such gap. 
The mathematical representations of cellular meta-
bolism have many facettes, ranging from topological
and stoichiometric descriptions to kinetic models of me-
tabolic pathways. We have applied the stoichiometric
one as it goes beyond merely topological arguments,
takes the specific relative quantities of reactants into
account, the reversibility/irreversibility of reactions, and 
allows putting constraints on the functional capabilities 
of metabolic networks. At the same time it does not re-
quire the knowledge of kinetic characteristics of enzy-
mes, concentrations of metabolites etc. which are diffi-
cult to obtain but are necessary for kinetic modeling.
The stoichiometric analysis largely relies on the steady
state assumption and does not allow accounting for al-
losteric regulation. 
We have addressed several questions – the impact
of elevated concentration of Hcy, down-regulated acti-
vities of methyleneTHF reductase (MTHFR; EC 1.5.1.
20), cystathionine β-synthase (CBS; EC 4.2.1.22), me-
thionine synthase (MS; EC 2.1.1.13),  Met nutritional
deficiency and several combinations of these factors in
the FOCM network in human placenta [45, 46]. Ele-
vated concentration of Hcy is a well known marker of
perturbations in the placental FOCM [37]; three en-
zymes are polymorphic, their mutated forms possess
lower catalytic activities than the wild forms and their
prevalence at Caucasians is substantial [42]. MTHFR
catalyses the reduction of 5,10-methyleneTHF to 5-me-
thylTHF which donates methyl group to methionine
21
                                                                                                         THE START OF SYSYEMS BIOLOGY IN UKRAINE   
Proteins Methylation
Methionine
SAM
SAH
Homocysteine
Cysteine
Cystathionine
Folate
Glutathione
5-CH3THF
5, 10-CHTHF
10-CHOTHF
RYRIMIDINES
PURINES
5, 10-CH2THF
THF
Cystathionine β-synthase
Serine
-CH3
MTHF reductase
Antioxidation Detoxication TaurineSulfate
Methionine
cycle
Fig. 2. The general scheme of
folate-mediated one-carbon
unit metabolism: 5-CH3THF –
5-methyltetrahydrofolate; 5,10-
CH2THF – 5,10-methylenetet-
rahydrofolate; THF – tetrahyd- 
rofolate; 5,10-CHTHF – 5,10-
methenyltetrahydrofolate; 10-
CHOTHF – 10-formyltetra-
hydrofolate; SAM – S-adeno-
sylmethionine; SAH – S-adeno-
sylhomocysteine
cycle; CBS is responsible for irreversible Hcy elimina-
tion and MS – for the synthesis of Met; methionine de-
ficiency is a frequent event among vegetarians, vegans
and vulnerable social groups. 
We have mined the literature for placental specific
gene expression of FOCM enzymes, for the first time
modeled placental specific FOCM and simulated the si- 
tuations close to real-life ones. The two wellknown va-
riants of stoichiometric analysis, namely elementary flux
modes (EFM) and flux balance analysis (FBA) were ap-
plied [45]. 
One common characteristic of the mentioned approa- 
ches is that they both compute the complete set of EFMs
given the network stoichiometry. EFM is a minimal
operational unit at steady state in metabolic networks
satisfying the thermodynamic constraint regarding the
reversibility of each reaction [46]. In other words, EFM 
is a minimal biochemical pathway that, at steady state,
catalyses a set of reactions between input and output
metabolites. Each metabolic network is characterized
by unique set of EFMs. 
We arranged all biochemical reactions in descen-
ding order according to their frequency in the set of
EFMs. Serine hydroxylmethytransferase (SHMT; EC
2.1.2.1) and serine (Ser) input are the most frequent
while the reactions of taurine synthesis are the least fre- 
quent ones pointing to the importance of the former as
main suppliers of one carbon units in FOCM and partial 
independence of the latter from folate metabolism. This 
conclusion coincides with experimental data [40, 41].
The simulation of the abovementioned situations has 
revealed that they affect the majority of reactions in the
network in quite specific way [45, 46]. For example,
the twofold increase in Hcy concentration is associated
with the down-regulation in the fluxes supporting the
synthesis of nucleic acids precursors and up-regulation
of cysteine production providing the elimination of Hcy
excess that correlates with the experimental data obtai-
ned on the placental explants cultivated with Hcy [39].
The C677T heterozygosity of MTHFR stimulates the
pronounced accumulation of Hcy, down-regulation of
Hcy remethylation and increasing requirement in 5-
MTHF. In this situation the folate therapy is justified
while in the case of MS deficiency the rapidly increa-
sing concentration of Hcy, down-regulated reactions of 
methionine cycle are associated with the inhibited flux
through MTHFR. In this case the folates prescription
will not improve the situation as the flux through
MTHFR is inhibited. In context with these results the
homozygous MS knockout mice embryos survive
through implantation but die soon thereafter. Nutri-
tional supplementation during pregnancy was unable to 
rescue embryos that were completely deficient in me-
thionine synthase [47]. 
As can be seen from above the simulation of close-
to-real-life situations in FOCM model induces on the
one hand the changes similar to those experimentally
obtained that underscore the validity of the model. On
the other hand the results of analysis draw attention to
several previously unknown interrelations in FOCM
that were not experimentally explored so far and have
to be taken into account. The more detailed analysis of
FOCM at the patients is required for the justified
therapy. 
Looking ahead. Therefore, the Systems Biology
has officially started in Ukraine and we have got nearly
four years experience and received our first results.
During the nearest time we intend to experimentally
verify the predictions made by COTRASIF, gene ex-
pression profiling, FOCM simulations and also master
the reconstruction and analysis of GRNs.  
Our general considerations refer to the perspectives 
of Systems Biology development in Ukraine. Under-
standing the function of complex biological systems is
one of the greatest challenges facing the modern sci-
ence. The scientific community in the world is going
along this way. Ukraine has all possibilities to move in
the same direction. We have highly qualified specia-
lists in different areas of fundamental science who
might master and spread the new knowledge in scien-
tific community. The courses on Systems Biology have 
to be included in the programs of high schools. The spe-
cial grants have to be established for the development
of Systems Biology. Systems Biology may start from
the pure computational biology using a wealth of avai-
lable data and software and widespread partnership
with our foreign colleagues but the investments in faci-
lities for high-throughput technologies are indispensab-
le. In conclusion – a journey of a thousand miles begins
with a single step. The first steps are already made in
the Institute of Molecular Biology and Genetics of
NAS of Ukraine. Let it be a start of great promise.
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Çà ïî ÷àò êó âàí íÿ ñèñ òåì íî¿ á³îëîã³¿ â Óêðà¿í³
Ì. Þ. Îáî ëå íñüêà, Á. Ò. Òî êî âåí êî, À. Â. Êóêë³í, À. Î. Ôðî ëî âà, 
Ð. Ð. Ðîäð³ãåñ, Â. À. Äî öåí êî, Î. Î. Äðà ãó ùåí êî
Ðå çþ ìå
Ïðåä ñòàâ ëå íî íà óêîâ³ çäî áóò êè ïåð øî¿ â Óêðà¿í³ (²ÌÁ³Ã ÍÀÍ
Óêðà¿ íè) ëà áî ðà òîð³¿ ñèñ òåì íî¿ á³îëîã³¿. Âîíè âêëþ ÷à þòü ñòâî -
ðåí íÿ âåá-³íñòðó ìåí òó äëÿ âñå ãå íîì íî ãî ïî øó êó ñàéò³â çâ’ÿ çó -
âàí íÿ òðàíñ êðèïö³éíèõ ôàê òîð³â ó ïðî ìî òî ðàõ åâêàð³îò íèõ ãå-
í³â; ðîç êðèò òÿ òîí êî çáà ëàí ñî âà íî ãî ìå õàí³çìó â³äïîâ³ä³ ïåð âèí -
íèõ ãå ïà òî öèò³â íà ä³þ ³íòåð ôå ðî íó àëü ôà â äîç³, çàðåºñòðî âà-
í³é íà ïåð øî ìó åòàï³ ðå ãå íå ðàö³¿ ïå÷³íêè ï³ñëÿ ÷àñ òêî âî¿ ãå ïàò-
åê òîì³¿; ðîç ðîá êó íî âî ãî ìå òî äó ³íôå ðåíö³¿ ìå ðåæ³ ãåí íî¿ ðå ãó -
ëÿö³¿ äëÿ éîãî âè êî ðèñ òàí íÿ â ñå ðå äî âèù³ ÃÐ²Ä ³ ñòâî ðåí íÿ ñòå-
õ³îìåò ðè÷ íî¿ ìî äåë³ ôî ëàò íî ãî öèê ëó ó ïëà öåíò³ ëþ äè íè äëÿ õà -
ðàê òå ðèñ òè êè ïî âåä³íêè ñèñ òå ìè çà ð³çíèõ ïà òî ëîã³÷íèõ ñòàí³â.
Êëþ ÷îâ³ ñëî âà: ñèñ òåì íà á³îëîã³ÿ, ãåíí³ ðå ãó ëÿ òîðí³ ìå ðåæ³,
ìå òà áîë³÷íå ìî äå ëþ âàí íÿ, ì³êðî à ðåé.
Còàðò ñèñ òåì íîé áè î ëî ãèè â Óêðà è íå
Ì. Þ.Îáî ëåí ñêàÿ,Á. Ò. Òî êî âåí êî, À. Â. Êóê ëèí, À. À. Ôðî ëî âà, 
Ð. Ð. Ðîä ðè ãåñ, Â. À. Äî öåí êî, À. À. Äðà ãó ùåí êî
Ðå çþ ìå
Ïðåä ñòàâ ëå íû íà ó÷íûå íà ðà áîò êè ïåð âîé â Óêðà è íå (ÈÌÁèÃ ÍÀÍ 
Óêðà è íû) ëà áî ðà òî ðèè ñèñ òåì íîé áè î ëî ãèè. Îíè âêëþ ÷à þò ñî -
çäà íèå âåá-èíñòðó ìåí òà äëÿ âñå ãå íîì íî ãî ïî èñ êà ñàé òîâ ñâÿ çû -
âà íèÿ òðàíñ êðèï öè îí íûõ ôàê òî ðîâ â ïðî ìî òî ðàõ ýó êà ðè î òè ÷åñ- 
êèõ ãå íîâ; ðàñ êðû òèå òîí êî ñáà ëàí ñè ðî âàí íî ãî ìå õà íèç ìà îò âå -
òà ïåð âè÷ íûõ ãå ïà òî öè òîâ íà äå éñòâèå èí òåð ôå ðî íà àëü ôà â
äîçå, ðå ãèñ òðè ðó å ìîé â ïå ÷å íè íà ðàí íåì ýòà ïå ïî ñëå ÷àñ òè÷ íîé
ãå ïà òýê òî ìèè; ðàç ðà áîò êó íî âî ãî ìå òî äà èí ôå ðåí öèè ñå òåé ãåí-
íîé ðå ãó ëÿ öèè äëÿ åãî èñ ïîëü çî âà íèÿ â ñðå äå ÃÐÈÄ è ñî çäà íèå ìî -
äå ëè ôî ëàò íî ãî öèê ëà â ïëà öåí òå ÷å ëî âå êà äëÿ õà ðàê òå ðèñ òè êè
ïî âå äå íèÿ ñèñ òå ìû ïðè ðàç íûõ ïà òî ëî ãè ÷åñ êèõ ñî ñòî ÿ íè ÿõ.
Êëþ ÷å âûå ñëî âà: ñèñ òåì íàÿ áè î ëî ãèÿ, ãåí íûå ðå ãó ëÿ òîð íûå
ñåòè, ìå òà áî ëè ÷åñ êîå ìî äå ëè ðî âà íèå, ìèê ðî àð ðåé.
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